ABT263 and ARV825 emerged as promising senolytic candidates based on our criteria. Nevertheless, 20–30% of senescent cells persisted after treatment with these compounds. To investigate why a subset of cells remained refractory, we examined scRNA-seq to profile the surviving population. Notably, sev...
ORGANISM(S): Homo sapiens